Blue Jet Healthcare Board of Directors
Get the latest insights into the leadership at Blue Jet Healthcare. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Akshay Bansarilal Arora | Executive Chairman |
| Mr. Shiven Akshay Arora | Managing Director |
| Mr. Naresh Suryakant Shah | Executive Director |
| Mr. Girish Paman Vanvari | Independent Director |
| Ms. Preeti Gautam Mehta | Independent Director |
| Ms. Divya Sameer Momaya | Independent Director |
Blue Jet Healthcare Share price
BLUEJET
708.35
2.75 (0.39%)NSE
BSE
Last updated on 4 Sep, 2025 | 15:59 IST
BUYSELL
Today's High
724.00
Today's Low
706.00
52 Week Low
460.50
52 Week High
1027.80
The current prices are delayed, login to your account for live prices
LoginBlue Jet Healthcare FAQs
The board at Blue Jet Healthcare consists of experienced professionals, including Mr. Akshay Bansarilal Arora , Mr. Shiven Akshay Arora , and others, overseeing the company’s strategic and corporate governance.
Directors at Blue Jet Healthcare are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Akshay Bansarilal Arora is the current chairman at Blue Jet Healthcare.
Executive directors at Blue Jet Healthcare are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Blue Jet Healthcare adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Blue Jet Healthcare, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.